Dawnrays Pharmaceutical (Holdings) Limited

Pharmaceutical industry · Hong Kong, Hong Kong

About Dawnrays Pharmaceutical (Holdings) Limited

Dawnrays Pharmaceutical (Holdings) Limited is a pharmaceutical company founded in 1995 and listed on the Main Board of the Hong Kong Stock Exchange (2348), headquartered in Wan Chai, Hong Kong, with production plants in mainland China, including Suzhou and Fujian. The group develops, manufactures and sells non-patented pharmaceutical medicines through two segments: intermediates and bulk medicines, and finished drugs.

Its historic speciality is cephalosporin antibiotics, with a complete chain from intermediates and bulk substances to powder for injections and oral preparations. Alongside this base it offers system-specific medicines: cardiovascular and antihypertensive products, anti-HBV antivirals such as entecavir, anti-allergy products such as cetirizine, and medicines for the digestive, urinary and endocrine systems.

Dawnrays sells nearly all of its production in mainland China and exports to other Asian markets. Its Suzhou technology research institute coordinates group-wide R&D on generic active ingredients and formulations, aiming to optimise processes and register new products that sustain its position in antibiotics and widely used chronic medicines.

Other businesses in Pharmaceutical industry